Similar articles

• [A phase II study of oral VP-16 in primary lung cancer].

  Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T, et al. Matsui Y, et al. Gan To Kagaku Ryoho. 1985 Sep;12(9):1801-7. Gan To Kagaku Ryoho. 1985. PMID: 2994576 Japanese.
• [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].

  Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S. Kado M, et al. Gan To Kagaku Ryoho. 1986 Jan;13(1):116-21. Gan To Kagaku Ryoho. 1986. PMID: 3002282 Japanese.
• Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.

  Slayton RE, Creasman WT, Petty W, Bundy B, Blessing JA. Slayton RE, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2089-92. Cancer Treat Rep. 1979. PMID: 526942 No abstract available.
• Etoposide (VP-16) in the treatment of lung cancer.

  Pedersen AG, Hansen HH. Pedersen AG, et al. Cancer Treat Rev. 1983 Dec;10(4):245-64. doi: 10.1016/0305-7372(83)90013-0. Cancer Treat Rev. 1983. PMID: 6318994 Review. No abstract available.
• [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].

  Goldhirsch A, Joss R, Cavalli F, Sonntag RW, Ryssel HJ, Brunner KW. Goldhirsch A, et al. Dtsch Med Wochenschr. 1981 Aug 28;106(35):1105-9. doi: 10.1055/s-2008-1070465. Dtsch Med Wochenschr. 1981. PMID: 6266800 Review. German. No abstract available.